While retatrutide shares some common side effects with GLP-1 receptor agonists, such as gastrointestinal events, the frequency and severity of these adverse events appear to be dose-dependent and can be reduced by the use of a lower starting doses of retatrutide
We confirmed that exendin-4 potentiated insulin secretion at 6 mmol/l glucose by 100% in both mouse and human islets (not shown)
doi: 10.1016/j.pharmthera.2020.107625 183 Khler-ForsbergOGasseCBerkMstergaardSD
(44) assessed the effects of a vitamin D, calcium, and leucine-enriched whey protein drink in 380 adults with sarcopenia for 13 weeks and reported suppression of parathyroid hormone, increased serum 25(OH)D, and accompanying small improvements in bone mineral density compared to an isocaloric control
De Silva A, Salem V, Long CJ, Makwana A, Newbould RD, Rabiner EA, et al